DNA vaccines against autoimmune type 1 diabetes (T1D) contain a nonpredictable risk to induce autoreactive T cell responses rather than a protective immunity. Little is known if (and how) antigen expression and processing requirements favor the induction of autoreactive or protective immune responses by DNA immunization. Here, we analyzed whether structural properties of preproinsulin (ppins) variants and/or subcellular targeting of ppins designer antigens influence the priming of effector CD8 + T cell responses by DNA immunization. Primarily, we used H-2 b RIP-B7.1 tg mice, expressing the co-stimulator molecule B7.1 in beta cells, to identify antigens that induce or fail to induce autoreactive ppins-specific (K b / A [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] and/or K b /B [22] [23] [24] [25] [26] [27] [28] [29] ) CD8 + T cell responses. Female NOD mice, expressing the diabetes-susceptible H-2 g7 haplotype, were used to test ppins variants for their potential to suppress spontaneous diabetes development. We showed that ppins antigens excluded from expression in the endoplasmic reticulum (ER) did not induce CD8 + T cells or autoimmune diabetes in RIP-B7.1 tg mice, but efficiently suppressed spontaneous diabetes development in NOD mice as well as ppins-induced CD8 + T cell-mediated autoimmune diabetes in PD-L1
À/À mice. The induction of a ppins-specific therapeutic immunity in mice has practical implications for the design of immune therapies against T1D in individuals expressing different major histocompatibility complex (MHC) I and II molecules.
INTRODUCTION
DNA vaccination is a potent strategy to induce autoreactive effector CD8 + T cell responses against self-antigens, e.g., preproinsulin
(ppins) in pancreatic beta cells, but can also lead to prophylactic immune responses calibrating T cell-mediated autoreactivity. 1, 2 In both scenarios, de novo priming of immune responses against the major beta cell autoantigen ppins is mandatory. However, little is known about the antigen expression and processing requirements that favor either the induction of autoreactive or protective immune responses. RIP-B7.1 tg mice expressing the proinflammatory immune checkpoint molecule B7.1 (CD80) 3 have been useful to study de novo priming of antigen-specific CD8 + T cells by DNA immunization and their subsequent pathogenic crosstalk with islet beta cells. [4] [5] [6] [7] [8] [9] [10] Transgenic expression of the B7.1 molecule in beta cells of RIP-B7.1 tg mice converts these cells into "professional-like" antigen-presenting cells (APCs) ( Figure S1A ). As a consequence, B7.1 + beta cells could directly interact with CD28 on T cells and stimulate de novo-primed or adoptively transferred autoreactive CD8 + T cells, finally leading to a CD8 + T cell-mediated destruction of beta cells and development of clinically overt disease, mimicking largely the situation in humans afflicted with T1D. 7, 8 Priming of ppins-specific autoreactive CD8 + T cells in RIP-B7.1 tg mice by DNA immunization did not require CD4 + T cell help. 7, 8 Therefore, RIP-B7.1 tg mice provide an attractive model system to identify beta-cell-specific antigens that are targeted by autoreactive T cells 4, [7] [8] [9] 11 and to identify designer antigens with the potential to mitigate autoreactive CD8 + T cells. 6 A single injection of ppins DNA selectively induced K b /A 12-21 -monospecific CD8 + T cells, whereas a mutant ppinsDA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Expression and processing of proteins in the ER and the secretory route might increase the presentation efficacy of autoantigen-derived epitopes that bind major histocompatibility complex (MHC) class I molecules with low affinity, 12-16 because they must not compete with the bulk of antigenic peptides generated in the conventional MHC I antigen-presentation pathway for transporters associated with antigen presentation (TAP)-dependent transport into the ER. At least the K b /A 12-21 epitope harbors a very low affinity for the K b molecule. 7 The K b /A 12-21 epitope represents the extreme COOH terminus of the ppins molecule (i.e., the insulin A-chain; Figure 1A ) and hence does not require COOH-terminal processing for loading MHC class I K b molecules in the ER. 6 However, K b /A 12-21 -specific CD8 + T cells were also induced by COOH terminally extended ppins fusion antigens expressed in the ER (e.g., in a pCI/ppins-GFP vector), but not when excluded from ER (e.g., in a pCI/GFP-ppins vector), indicating that the epitope position at the COOH terminus is less important for T cell population ± SD. Statistical analysis was performed using a repeated-measures one-way ANOVA followed by Tukey's multiple comparisons. *p < 0.05; **p < 0.01; ns, not significant.
its antigenicity than antigen targeting to the ER. 6 The insulin B-chain K b /B [22] [23] [24] [25] [26] [27] [28] [29] epitope is localized close to the B/C junction of ppins (Figure 1A ) and therefore requires both processing at the COOH and NH 2 terminus. We thus hypothesized that intrinsic properties of the antigen and/or antigen processing and presentation in the ER contribute to the induction of autoreactive ppins-specific CD8 + T cell responses. ) have been exploited extensively to study diabetes development as well as to develop immunotherapies to prevent diabetes. 19 The MHC class II I-A g7 molecule in NOD mice, as specific human leukozyte antigen (HLA) haplotypes (DQ2; DQ8) in humans, 20 is a major determinant for developing disease but expressed in an otherwise nonsusceptible genetic background (B6 or nonobese resistant NOR/Lt mice) is not sufficient for diabetes development. Though the pace of insulitis and disease development differs substantially in man and NOD mice and many translating therapies from NOD mice to humans failed, 19 there are also several promising approaches. Peptide-based 21 and vector-DNA-based 22 immunotherapies have been successfully used in human trials. Vectors expressing proinsulin (pins) reduced the incidence of spontaneous diabetes development in NOD mice 23 and reduced the frequency of autoreactive CD8 + T cells in patients with T1D. 22 However, genetic vaccination with ppins-expressing DNA accelerated spontaneous diabetes development in female NOD mice and diminished the natural diabetes resistance in male NOD mice. 4 This exemplifies that DNA vaccines against T1D contain a nonpredictable risk to induce autoreactive T cell responses rather than a protective immunity. We show here that ppins designer antigens expressed in or outside the ER exert a strong impact on induction of epitope-specific CD8 + T cells by DNA immunization and the development of autoimmune diabetes in different mouse models of type 1 diabetes. In particular, ppins designer antigens excluded from expression in the ER efficiently suppressed spontaneous diabetes development in the NOD mouse model. Figure S2 ). Overall, these findings indicated that antigen-specific properties of endogenously expressed ppinsDA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] were not the primary cause for the priming of K T cells in RIP-B7.1 tg mice. We previously showed that ppins antigens, targeted to the cytosol and/or the nucleus by fusing the ppins sequence COOH terminally to the GFP (pCI/GFP-ppins) or to a 77-residue stress protein (Hsp73)-binding domain of the SV40 large T antigen 24 (pCI/cT77-ppins), were excluded from expression and processing in the ER and did not induce autoimmune diabetes in RIP-B7.1 tg mice ( Figure S3 ). 6 Because these fusion antigens contain large heterologous protein sequences ( Figure S3 ) that could induce illdefined immune responses and thereby influence priming of autoreactive CD8 + T cells, we generated a small nuclear pins construct by exchanging the sequence of the ER-targeting signal peptide of ppins (SP) with a 19-amino-acids-long SV40 T-Ag-derived nuclear localization sequence (NLS; pCI/NLS-pins) (Figure 2A ). To facilitate detection of this antigen, we fused an HA-tag sequence COOH terminally in frame to the NLS-pins sequence ( Figure 2A ). The NLS-pins antigen was stably expressed in the nucleus of transiently transfected HEK293 cells ( Figures 2B and 2C) . Injection of the pCI/NLS-pins vector into RIP-B7.1 tg mice did not induce autoimmune diabetes (Figure 2D) . Furthermore, no signs of CD8 + T cell infiltration into islets or destruction of islets were detectable in pCI/NLS-pins-immune RIP-B7.1 tg mice by histology ( Figure 2E ). Overall, these findings confirmed that prevention of antigen expression in the ER did not allow de novo priming of autoreactive effector CD8 + T cells in RIP-B7.1 tg mice by DNA immunization.
RESULTS

Deletion or
We previously showed that injection of pCI/ppins but not pCI/ ppinsDA 12 18 Similarly, pCI/GFP-ppins or pCI/NLS-ppins vectors did not induce autoimmune diabetes in PD-L1-deficient mice ( Figure 3A) and efficiently suppressed CD8 + T-cell-mediated diabetes induction by a subsequent injection of the pCI/ppins vector ( Figure 3B ). In line with our previous findings, injection of pCI/GFP-ppins significantly increased Foxp3 + CD25 + CD4 + Treg cell frequencies in PD-L1 À/À mice ( Figure S4) . 18 This confirmed that ppins antigens Figure 4A ). Diabetes development is characterized by continuous lymphoid cell accumulations in the periphery of pancreatic islets (peri-insulitis) and infiltration of the islets (insulitis) ( Figures 5A and 5B) , finally leading to the destruction of beta cells and the development of severe hyperglycemia. 20 To determine whether ppins designer antigens could induce a tolerogenic immune response in NOD mice, we injected pCI/NLS-pins or pCI/GFP-ppins vectors and different pCI-based control vectors six times in biweekly intervals into young female NOD mice, starting at the age of 10-12 weeks (Figures 4 and 5) . As expected at this age, islets already showed signs of an initial damage with a prominent insulitis ( Figure 5B , group 1), 19 whereas clinical signs of diabetes were still absent, with blood glucose levels below the threshold of 250 mg/dl (deciliter). Therefore, the destructive autoreactive immune response in the islets was already underway before DNA vaccination. In this therapeutic setting, we showed that vaccination of prediabetic (B) Furthermore, NOD mice were immunized with the "empty" pCI vector (n = 22), pCI/ppinsDA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] (n = 10), or pCI/grp40 (n = 10). Injections were repeated six times in bi-weekly intervals. Diabetes development was monitored by regular blood glucose measurements. Kaplan-Meier curves of diabetes-free survival in the different study cohorts were compared using log-rank test. (*p < 0.05, **p < 0.01, ***p < 0.001); ns, not significant. Figure 5 . Suppression of the Pathogenic T Cell Infiltration into Islets of NOD Mice by pCI/NLS-pins and pCI/GFP-ppins Vaccines (A) The continuous T cell infiltration into the islets was determined in untreated NOD mice by H&E staining of the islets. For the semiquantitative evaluation of islet infiltration, H&E-stained sections containing more than five islets were selected, and 20-30 islets per pancreas were evaluated. The extent of lymphoid islet infiltration was scored from 0 to 3 as follows: score 0 = healthy (no infiltration with lymphocytes detectable); score 1 = peri-insulitis (lymphocytes surrounding the islets); score 2 = insulitis with a <50% infiltration of the islets with lymphocytes; score 3 = severe insulitis with an extensive >50% infiltration of the islets with lymphocytes. Representative images of insulitis levels corresponding to the respective scores are shown. Scale bar, 50 mm.
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(B) The actual progress of spontaneous diabetes development was determined in untreated nondiabetic (10-12 weeks old, n = 5) and diabetic (20 weeks old, n = 5) NOD mice: score 0 (black), score 1 (light gray, cross-striped), score 2 (gray), score 3 (light gray).
(C) The actual T cell infiltration of islets (insulitis scores 2 + 3) was determined in untreated diabetic (n = 5) NOD mice and compared with healthy, pCI/GFP-ppins (n = 4) or pCI/NLS-pins (n = 3) immune NOD mice. For statistical analysis, a repeated-measures one-way ANOVA followed by Tukey's pairwise comparisons was used. *p < 0.05; ns, not significant.
female NOD mice ( Figure 4B ). Likewise, injection of the "empty" pCI vector or a vector expressing the G-protein-coupled receptor GPR40 (pCI/GRP40) did not affect spontaneous diabetes development in NOD mice ( Figure 4B) . As compared to 20-week-old untreated, diabetic NOD mice, suppression of diabetes development in age-matched pCI/GFP-ppins-or pCI/NLS-pins-immune and healthy NOD mice correlated with a substantial reduction of lymphoid cell infiltrations (insulitis) into the islets ( Figure 5C ). Similarly, immunofluorescence staining of pancreata from healthy (vaccinated with pCI/GFP-ppins vector) NOD mice confirmed the perpetuation of insulin production in the islets and the little infiltration of islets with CD8 + T cells and CD4 + T cells ( Figure S5A ). In contrast, pancreatic islets of diabetic NOD mice (e.g., injected with "empty" pCI vector) showed a massive infiltration with CD8 + T cells and CD4 + T cells and insulin-producing beta cells were largely destroyed ( Figure S5B ). Overall, these findings showed that DNA vaccines expressing ppins or pins designer antigens excluded from ER efficiently inhibited an ongoing autoreactive immune response in NOD mice.
DISCUSSION
Here, we describe a novel strategy to prevent diabetes development in murine models of T1D through DNA vaccination. Vector-expressed designer antigens that targeted ppins to the cytosol and/or the nucleus and thus are excluded from direct expression and processing in the Many beta cell antigens (e.g., ppins, glutamic acid decarboxylase, or islet-specific glucose-6 phosphatase catalytic subunit-related protein [IGRP] ) are presented by individual MHC class I molecules on the surface of beta cells in NOD mice and man and thus are potential targets for autoreactive CD8 + T cells. 19 There is increasing evidence from patients with T1D that CD8 + T cells play a crucial role in the development of disease. [25] [26] [27] [28] [29] [30] At least in NOD mice, ppins or insulin is the primary beta cell autoantigen targeted by autoreactive CD4 + and CD8 + T cells 31 and thereby triggers the initial steps of beta cell destruction and inflammation.
32 CD8 + T cells specific for the islet-specific IGRP accumulate in NOD mice but not in tg NOD mice that are tolerant to pins. 33 An initial T cell response against pins is thus a prerequisite for the development of IGRP-specific CD8 + T cells. 33 These early ppins-specific immune responses could subsequently drive the induction and/or expansion of multi-specific autoreactive T cell responses to other beta cell antigens. 31, 33, 34 We here showed that ppins designer antigens excluded from ER expression are smart vaccination tools to fulfill these requirements.
Here, we showed that antigen expression in the ER is crucial to prime CD8 + T-cell-mediated diabetes. Antigens not expressed in the ER (i.e., pCI/GFP-ppins and pCI/NLS-pins) did not induce diabetes. However, we previously showed that a pCI/pins vector, generated from pCI/ppins by removing the SP domain, expressed an instable protein in the cytosol. Comparable to the mutant ppinsDA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] antigen, proteasome-mediated degradation of pins resulted in a high turnover of this antigen in transiently transfected cells. 6, 8 Injection of pCI/pins into RIP-B7.1 tg mice inefficiently induced late-onset autoimmune diabetes, 6 but we could not unequivocally assign CD8 + T cell specificities to diabetes development. Therefore, this antigen contains a residual risk to develop diabetes, though pins expressing DNA vaccines were successfully used in NOD mice 23 and patients with T1D to induce a tolerogenic immunity. 22 The ppins K b /A 12-21 epitope, representing the COOH terminus of the ppins molecule, does not require COOH-terminal processing for loading to K b molecules in the ER. 6 Similarly, a B 22-30 epitope precursor with an almost exact COOH terminus (i.e., the B 22-30 peptide with one additional serine residue at position B30) could be generated in insulin-producing islet beta cells by beta cell-specific prohormone convertases PC2 and PC3 (cleaving between the B and C and C and A junctions, respectively) and by carboxypeptidase E (removing the COOH-terminal, basic arginine residues of the B/C junction; Figure S1B ). 38 However, these enzymes were not expressed in non-beta cells (i.e., in vector-transfected APCs in the muscle). 38 The processing mechanism(s) involved in the generation of the K b /B 22-29 peptide in nonbeta cells and its loading to K b molecules are yet unknown, but, at least for the mutant ppinsDA [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] antigen, may depend on its instable, proteasome-mediated high turn-over expression in transfected nonbeta cells. 8 In line with this, secretory or transmembrane proteins often contain MHC class I epitopes in their ER-targeting NH 2 -terminal signal peptides (SPs). SPs translocate proteins into the ER and are cleaved there by ER-resident signal peptidases (SPases). This often generates MHC class I epitope(s) with an exact COOH terminus. This has been shown to occur for two overlapping HLA-A0201-binding epitopes (ppins [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] and ppins [17] [18] [19] [20] [21] [22] [23] [24] ) in the SP of human ppins. 27 ER-resident aminopeptidase ERAP1, 39 but also signal peptide peptidases (SPPases) 40, 41 can further process the NH 2 -terminal www.moleculartherapy.org epitope-flanking sequences. Processing and presentation of these epitopes in the ER required neither proteasomes nor TAP, 27,42 thus differing from the conventional endogenous antigen-processing pathway, in which the majority of MHC class I-binding peptides are generated by the proteasome complex followed by TAP-mediated peptide translocation into the ER. 43 However, several epitopes (and CD8 + T cells) were also identified in the human ppins SP that contain COOH termini far away from the natural SPase processing site at position 24/25 (HLA-A*24/ppins [3] [4] [5] [6] [7] [8] [9] [10] [11] ; HLA-B*39/ppins [5] [6] [7] [8] [9] [10] [11] [12] ; HLA-B*38/ ppins [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . 28, 41 These epitopes are processed in the ER and/or the ER membrane by ER-associated SPases and SPPases, released into the cytoplasm and further processed for MHC I binding in a proteasomeand TAP-dependent manner. 28 18 However, we and others 23 could not unequivocally assign vaccine-primed functional regulatory Tregs to the suppression of spontaneous autoimmune diabetes in NOD mice. In our hands, injection of Treg-targeting anti-CD25 monoclonal antibody (mAb) into prediabetic NOD mice at the age of 10-12 weeks but also injection of anti-CD25 or anti-CD8 mAbs into early diabetic NOD mice (with blood glucose levels between 250 and 350 mg/dl) was inefficient and attenuated diabetes progression only in about 15%-20% of mice (data not shown). Defects in the complement system, 49 but also in many immunological pathways [50] [51] [52] [53] in NOD mice may limit the use of these mice to elucidate the molecular mechanisms involved in vaccine-induced tolerogenic immune response.
In summary, we presented two main new findings: (1) changing the structural integrity of the vector-encoded ppins protein affected the priming of effector CD8 + T cells in an epitope-specific manner; and (2) changing the natural expression of ppins in the ER prevented priming of ppins-specific CD8 + T cells, suppressed the potential multi-specific immune response against beta cell antigens, and protected NOD mice from diabetes development. DNA vaccines expressing selected ppins designer antigens are thus an attractive strategy for the improvement of immune therapies against T1D.
MATERIALS AND METHODS
Mice RIP-B7. 
Construction of Expression Plasmids
The antigenic sequences of the ppins variants were codon optimized and synthesized by GeneArt (Regensburg, Germany) or generated from these constructs by standard cloning techniques. All constructs were cloned into the pCI vector (cat. no. E1731, Promega, Mannheim, Germany) using the NheI and NotI restriction sites. Batches of DNA were produced in E. coli using the QIAGEN Plasmid Mega Kit (cat. no. 12183; QIAGEN, Hilden, Germany). 8, 18 Where indicated, cells were co-transfected with vectors encoding the L-RFP-ER protein (the red fluorescent protein [RFP] fused NH 2 -terminally with a Igkleader sequence and COOH terminally with the ER-retention signal SEKDEL) or encoding a red fluorescent mRuby-histone 2B protein using the Nanofectin transfection reagent (cat. no. Q051/005, PAA Laboratories, Cölbe, Germany). For co-localization studies, cells were transfected with the indicated plasmids, fixed with 2% paraformaldehyde (PFA), and permeabilized with 0.2% Triton X-100, 48 hr post-transfection. Fish-skin gelatin (0.2%) was used as blocking reagent. Cells were stained for expression of the recombinant proteins, using rabbit H-86 anti-insulin antibody or mouse anti-HA-Tag antibody (6E2, cat. no. 2367, Cell Signaling, Denver, MA, USA), followed by Alexa Fluor 488-conjugated goat anti-rabbit IgG (cat. no. ab150077, Abcam, Cambridge, UK) or Alexa Fluor 488-conjugated goat anti-mouse IgG (cat. no. ab150113, Abcam), respectively. Images were acquired with a fluorescence microscope (IX71; Olympus) equipped with a digital camera (C4742; Hamamatsu), a 100-W mercury lamp (HBO 103W/2; Osram), and the following filter sets: GFP, excitation HQ470/40, emission HQ525/50; RFP, excitation HQ545/ 30, emission HQ610/75 (AHF Analysentechnik). Editing of the pictures was performed using ImageJ software (https://imagej.nih.gov/ if/).
Histology
H&E and immunofluorescence staining of frozen pancreatic sections was performed as described previously. 8, 18 and group sizes are stated in the figure descriptions. For the evaluation of statistical differences in the mean T cell frequencies between groups and differences between insulitis grades of the differently treated NOD study cohorts, one-way ANOVA followed by Tukey's multiple comparisons (with 95% confidence intervals) was used. (*p < 0.05, **p < 0.01, ***p < 0.001) The statistical significance of diabetes induction in immunized female NOD mice was determined by the log-rank (Mantel-Cox) test.
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